Research may lead to new and improved vaccines

Mar 14, 2011
Yan Shi, Ph.D., (L) and Tracy Flach are in their University of Calgary lab. Credit: Bruce Perrault

Alum is an adjuvant (immune booster) used in many common vaccines, and Canadian researchers have now discovered how it works. The research by scientists from the University of Calgary's Faculty of Medicine is published in the March 13 online edition of Nature Medicine. The new findings will help the medical community produce more effective vaccines and may open the doors for creating new vaccines for diseases such as HIV or tuberculosis.

"Understanding alum properties will help other vaccines because we are one step deeper into the mechanistic insight of adjuvants, which are essential for human vaccines to work," says Yan Shi, PhD, from the Faculty of Medicine and a member of the Snyder Institute of Infection, Immunity and Inflammation.

Alum is a common grocery store staple used in pickling. It is very effective in inducing antibody responses and is the only human adjuvant approved for large-scale immunization. It has been in use for 90 years and appears in almost all vaccines we receive as without an adjuvant vaccines in general do not work.

"Knowledge provided in this study may help us manipulate alum with additional adjuvant components to direct an attack against major diseases which require a killer T such as HIV, Tuberculosis, and malaria," says Tracy Flach from the Faculty of Medicine and the study's first author.

The research reveals that alum interacts with a group of immune cells called dendritic cells via their cell membrane lipids. Dendritic cells, the sentinel of our immune system, heed the call of alum and move on to activate a group of that control antibody production.

The breakthrough came as the team made use of a cutting edge technology developed in the Faculty of Medicine called single cell force spectroscopy. This technique allowed the UCalgary team to study individual and measure their responses to alum.

Explore further: Unsteady on your feet? Little touches could make all the difference

Related Stories

New 'adjuvant' could hold future of vaccine development

Sep 14, 2009

Scientists at Oregon State University have developed a new "adjuvant" that could allow the creation of important new vaccines, possibly become a universal vaccine carrier and help medical experts tackle many diseases more ...

Tattooing improves response to DNA vaccine

Feb 07, 2008

A tattoo can be more than just a fashion statement – it has potential medical value, according to an article published in the online open access journal, Genetic Vaccines and Therapy.

Recommended for you

Neutralising antibodies for safer organ transplants

19 hours ago

Serious complications can arise following kidney transplants. If dialysis is required within the first seven days, then the transplanted organ is said to have a Delayed Graft Function (DGF), and essentially ...

User comments : 0